An industry-sponsored expert panel issued statements recommending tirbanibulin as first-line actinic keratosis treatment.
Almirall, S.A. (ALM) a global biopharmaceutical company dedicated to medical dermatology, is a major contributor to the 2025 ...
All 172 patients have now entered the 12-month follow-up phaseTrial involves larger surface areas, building on the approval in October 2024 for ...
Welcome to the annual anti-inflammatory version of The Dry Eye.You are probably wondering what the heck there is to say about ...
Prominent players in the market are Stena Metall Group, Radius Recycling, Boliden AB, Metallo-Chimique International N.V., ...
Onlymyhealth on MSN
What Is Eyelid Disease? Causes, Symptoms, Treatment, And Prevention
Eye disease is a group of conditions that affect the eyelid Causes symptoms and treatment depend on the type of condition you ...
This release is being retransmitted for extra exposure to downstream sites. SHELTON, CT / ACCESS Newswire / September 11, ...
OT presents key takeaways from the Specsavers Professional Advancement Conference in Birmingham ...
During a live event, Kit Yu Lu, MD, discussed data on antibody-drug conjugates in HR+, HER2- breast cancer including the ...
The dash for metabolic dysfunction hepatic steatohepatitis (MASH) is gaining momentum, with Roche AG acquiring 89bio Inc. and its phase III FGF21 analogue, pegozafermin, in a deal worth up to $3.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback